Valtrex is also approved to help heal the lesions and to lessen the pain of an initial episode of genital herpes. While the majority of the population has been exposed to HSV-1, not everyone develops cold sores. Many people say they feel a tingle valtrex daily or prodrome before the blisters actually form. Cold sores, also known as herpes labialis or fever blisters, are highly infectious sores on the lip and outer edge of the mouth. In this study, patients with primary herpes zoster applied ARYS-01 cream twice daily for 7 days. It is estimated that 1 in 5 Americans are infected with the virus that causes genital Valtrex daily herpes. In fact, one study (Mertz et al) has confirmed that up to 70 percent of transmission of genital herpes may occur without symptoms being present. Valtrex offers once-daily dosing for the suppression of genital herpes outbreaks, as well as a three-day treatment for recurrent outbreaks of genital herpes. In this study, VALTREX was valtrex daily generally well-tolerated. The study undertaken in support of the sNDA showed that once-daily valtrex daily suppressive therapy with VALTREX 500 mg caplets reduced transmission of symptomatic genital herpes (signs or symptoms of an outbreak confirmed with a lab test) by 75 percent versus placebo (0. 5 percent vs 2. 2 valtrex daily percent) in 1484 healthy, heterosexual, monogamous couples. Valtrex is currently indicated for the treatment or suppression of genital herpes in healthy individuals and for the suppression of recurrent genital herpes in HIV-infected adults with valtrex daily cd4+ counts [greater than or equal to] 100 cells/uL. Janus Pharmaceuticals is planning a phase II/III trial of ARYS-01 in early 2007. After 6 months, the proportion of patients taking valacyclovir who were recurrence-free was 65%, compared with 26% of those receiving placebo. Median time to first recurrence was greater than 180 days valtrex daily for patients receiving valacyclovir compared with 59 days for those receiving placebo. The most valtrex daily common adverse events in the study were headache, fatigue, and rash. According to the medication’s labeling, valacyclovir is intended for suppression of genital herpes in HIV-infected adults with CD4+ counts above 100 cells/[mu]L. Food and Drug Adminis-tration has approved a supplemental new drug application (sNDA) for VALTREX[R] (valacyclovir HCI) caplets in the treatment of cold sores in healthy adults. The committee’s favorable recommendation will be considered by the FDA in its review of the supplemental new drug application (sNDA) GSK has submitted for VALTREX. For more information, contact GlaxoSmithKline by calling 888-825-5249. GlaxoSmithKline announced that the U. Food and Drug Administration (FDA) Advisory Committee unanimously (13-0) recommended the approval of once-daily suppressive therapy with VALTREX(R) (valacyclovir valtrex daily hcl) for the reduction of transmission of genital herpes in otherwise healthy, heterosexual, monogamous couples. Food and Drug Administration (FDA).